Horizon scanning implanted biosensors in personalising breast cancer management: First pilot study of breast cancer patients views.

ABSTRACT:

Aims

This study aimed to explore breast cancer patients' understanding and acceptability of implanted biosensors (BS) within the primary tumour to personalise adjuvant radiotherapy, and to determine optimal design and number of BS, and evaluate potential clinical benefits as well as concerns about tolerance, toxicity, dwell time, and confidentiality of data.

Patients and methods

A total of 32 patients treated by surgery (29 breast conserving, 3 mastectomy), postoperative radiotherapy and systemic therapy for early breast cancer, were recruited from a posttreatment radiotherapy clinic at a cancer centre. Patients participated in semistructured interviews. Interview transcripts were analysed using qualitative methods.

Results

Participants were aged 39 to 87 years, with

SUBMITTER: Ikegwuonu T 

PROVIDER: S-EPMC6266376 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature